SELL and neoplasm: CD4+ and CD8+ effector T lymphocytes (CD3+/ CD44+/ CD62L−) were measured in spleen, DLNs, and tumor tissues, considering their relevance in the elimination of solid tumors and their value for tumor prognosis.